Eaton Vance Management Moderna, Inc. Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Moderna, Inc. stock. As of the latest transaction made, Eaton Vance Management holds 484,689 shares of MRNA stock, worth $19.1 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
484,689
Previous 485,150
0.1%
Holding current value
$19.1 Million
Previous $69.3 Million
17.3%
% of portfolio
0.08%
Previous 0.1%
Shares
8 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.67 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.58 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.01 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$664 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$285 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...